A study in mice and people from the School of Medicine shows that sleep deprivation causes tau levels to rise and tau tangles to spread through the brain, accelerating Alzheimer’s brain damage.
The Brown School and Washington University School of Medicine in St. Louis have received a $2.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the impact of addressing unmet basic needs among Medicaid beneficiaries with diabetes.
A group of medical students at Washington University School of Medicine in St. Louis has launched a new initiative aimed at supporting equal advancement in the medical profession. The effort is called 500 Women in Medicine.
A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer’s disease – even before they show signs of confusion and memory loss, according to a new study from the School of Medicine and the German Center for Neurodegenerative Diseases.
A day in the life of Washington University School of Medicine showcases the breadth of ongoing efforts to advance research, education and the best medical care possible for patients.
Monique Williams, AB ’95, MD ’99, MSCI ’08, is a physician with expertise in geriatric medicine and an advocate for including underrepresented populations in medical studies.
Alexis Elward, MD, was named St. Louis Children’s Hospital chief medical officer. The appointment became effective Jan. 1.
By tweaking the recipe for coaxing human stem cells into insulin-secreting beta cells, a team of researchers at the School of Medicine has shown that the resulting cells are more responsive to fluctuating glucose levels in the blood. The finding may lead to a new approach to treating diabetes.
The issue of ever-changing health care, particularly drug discovery, care delivery and introducing new technologies, will be the topic of a morning-long symposium Jan. 23 at Washington University in St. Louis’ Olin Business School as part of the David R. Calhoun Lectureship.
In a new study from the School of Medicine, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders.